Technology Evolution: Is It Survival of the Fittest?
New technologies are constantly being developed and introduced into medical practice. Their potential or actual use raises questions of efficacy and cost. All too often financial considerations of profit primarily determine whether a technology will be adopted. In an era in which the need to control...
Gespeichert in:
| Veröffentlicht in: | Journal of clinical oncology 2010-09, Vol.28 (27), p.4275-4279 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 4279 |
|---|---|
| container_issue | 27 |
| container_start_page | 4275 |
| container_title | Journal of clinical oncology |
| container_volume | 28 |
| creator | ZIETMAN, Anthony GOITEIN, Michael TEPPER, Joel E |
| description | New technologies are constantly being developed and introduced into medical practice. Their potential or actual use raises questions of efficacy and cost. All too often financial considerations of profit primarily determine whether a technology will be adopted. In an era in which the need to control costs has become clear, this situation is undesirable. The assessment of efficacy can, however, be very difficult, and the control of financial aspects is likewise problematic. In this article, we address these problems and suggest potential solutions, using proton radiotherapy as an example that may be relevant to the development of other medical devices. |
| doi_str_mv | 10.1200/JCO.2010.29.4645 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_755189246</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>755189246</sourcerecordid><originalsourceid>FETCH-LOGICAL-c402t-7f54c1544c43893ac25c2e866502e2a1b6dbb73eef19cae2be5de7b37e1d898f3</originalsourceid><addsrcrecordid>eNpFkEFPwzAMRiMEYmNw54R6QZw6EidpWi4ITQOGJnEAJG5Rmrq0U9ZA0w7x7-nEgJNl6fmz_Qg5ZXTKgNLLh9njFOjQQTYViZB7ZMwkqFgpKffJmCoOMUv564gchbCilImUy0MyAppkiioxJuIZbdV459--ovnGu76rfXMVLUK06KKnvt3UG-MiX0ZdhdFt3XUYuutjclAaF_BkVyfk5Xb-PLuPl493i9nNMraCQherUgrLpBBW8DTjxoK0gGmSSAoIhuVJkeeKI5YsswYhR1mgyrlCVqRZWvIJufjJfW_9Rz9s1us6WHTONOj7oIcvWZqBSAaS_pC29SG0WOr3tl6b9kszqreq9KBKb1VpyPRW1TBytgvv8zUWfwO_bgbgfAeYYI0rW9PYOvxzHARInv1fWdVv1Wfdog5r49wQC3plPaQalBagJP8GYKx9QA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>755189246</pqid></control><display><type>article</type><title>Technology Evolution: Is It Survival of the Fittest?</title><source>MEDLINE</source><source>American Society of Clinical Oncology Online Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>ZIETMAN, Anthony ; GOITEIN, Michael ; TEPPER, Joel E</creator><creatorcontrib>ZIETMAN, Anthony ; GOITEIN, Michael ; TEPPER, Joel E</creatorcontrib><description>New technologies are constantly being developed and introduced into medical practice. Their potential or actual use raises questions of efficacy and cost. All too often financial considerations of profit primarily determine whether a technology will be adopted. In an era in which the need to control costs has become clear, this situation is undesirable. The assessment of efficacy can, however, be very difficult, and the control of financial aspects is likewise problematic. In this article, we address these problems and suggest potential solutions, using proton radiotherapy as an example that may be relevant to the development of other medical devices.</description><identifier>ISSN: 0732-183X</identifier><identifier>EISSN: 1527-7755</identifier><identifier>DOI: 10.1200/JCO.2010.29.4645</identifier><identifier>PMID: 20697074</identifier><language>eng</language><publisher>Alexandria, VA: American Society of Clinical Oncology</publisher><subject>Biological and medical sciences ; Clinical Trials as Topic ; Cost Control ; Diffusion of Innovation ; Equipment Design ; Evidence-Based Medicine ; Health Care Costs ; Humans ; Medical sciences ; Patient Selection ; Protons - therapeutic use ; Radiotherapy - economics ; Radiotherapy - instrumentation ; Technology Transfer ; Treatment Outcome ; Tumors</subject><ispartof>Journal of clinical oncology, 2010-09, Vol.28 (27), p.4275-4279</ispartof><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c402t-7f54c1544c43893ac25c2e866502e2a1b6dbb73eef19cae2be5de7b37e1d898f3</citedby><cites>FETCH-LOGICAL-c402t-7f54c1544c43893ac25c2e866502e2a1b6dbb73eef19cae2be5de7b37e1d898f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,3729,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23242539$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20697074$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>ZIETMAN, Anthony</creatorcontrib><creatorcontrib>GOITEIN, Michael</creatorcontrib><creatorcontrib>TEPPER, Joel E</creatorcontrib><title>Technology Evolution: Is It Survival of the Fittest?</title><title>Journal of clinical oncology</title><addtitle>J Clin Oncol</addtitle><description>New technologies are constantly being developed and introduced into medical practice. Their potential or actual use raises questions of efficacy and cost. All too often financial considerations of profit primarily determine whether a technology will be adopted. In an era in which the need to control costs has become clear, this situation is undesirable. The assessment of efficacy can, however, be very difficult, and the control of financial aspects is likewise problematic. In this article, we address these problems and suggest potential solutions, using proton radiotherapy as an example that may be relevant to the development of other medical devices.</description><subject>Biological and medical sciences</subject><subject>Clinical Trials as Topic</subject><subject>Cost Control</subject><subject>Diffusion of Innovation</subject><subject>Equipment Design</subject><subject>Evidence-Based Medicine</subject><subject>Health Care Costs</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Patient Selection</subject><subject>Protons - therapeutic use</subject><subject>Radiotherapy - economics</subject><subject>Radiotherapy - instrumentation</subject><subject>Technology Transfer</subject><subject>Treatment Outcome</subject><subject>Tumors</subject><issn>0732-183X</issn><issn>1527-7755</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkEFPwzAMRiMEYmNw54R6QZw6EidpWi4ITQOGJnEAJG5Rmrq0U9ZA0w7x7-nEgJNl6fmz_Qg5ZXTKgNLLh9njFOjQQTYViZB7ZMwkqFgpKffJmCoOMUv564gchbCilImUy0MyAppkiioxJuIZbdV459--ovnGu76rfXMVLUK06KKnvt3UG-MiX0ZdhdFt3XUYuutjclAaF_BkVyfk5Xb-PLuPl493i9nNMraCQherUgrLpBBW8DTjxoK0gGmSSAoIhuVJkeeKI5YsswYhR1mgyrlCVqRZWvIJufjJfW_9Rz9s1us6WHTONOj7oIcvWZqBSAaS_pC29SG0WOr3tl6b9kszqreq9KBKb1VpyPRW1TBytgvv8zUWfwO_bgbgfAeYYI0rW9PYOvxzHARInv1fWdVv1Wfdog5r49wQC3plPaQalBagJP8GYKx9QA</recordid><startdate>20100920</startdate><enddate>20100920</enddate><creator>ZIETMAN, Anthony</creator><creator>GOITEIN, Michael</creator><creator>TEPPER, Joel E</creator><general>American Society of Clinical Oncology</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20100920</creationdate><title>Technology Evolution: Is It Survival of the Fittest?</title><author>ZIETMAN, Anthony ; GOITEIN, Michael ; TEPPER, Joel E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c402t-7f54c1544c43893ac25c2e866502e2a1b6dbb73eef19cae2be5de7b37e1d898f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Biological and medical sciences</topic><topic>Clinical Trials as Topic</topic><topic>Cost Control</topic><topic>Diffusion of Innovation</topic><topic>Equipment Design</topic><topic>Evidence-Based Medicine</topic><topic>Health Care Costs</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Patient Selection</topic><topic>Protons - therapeutic use</topic><topic>Radiotherapy - economics</topic><topic>Radiotherapy - instrumentation</topic><topic>Technology Transfer</topic><topic>Treatment Outcome</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>ZIETMAN, Anthony</creatorcontrib><creatorcontrib>GOITEIN, Michael</creatorcontrib><creatorcontrib>TEPPER, Joel E</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of clinical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>ZIETMAN, Anthony</au><au>GOITEIN, Michael</au><au>TEPPER, Joel E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Technology Evolution: Is It Survival of the Fittest?</atitle><jtitle>Journal of clinical oncology</jtitle><addtitle>J Clin Oncol</addtitle><date>2010-09-20</date><risdate>2010</risdate><volume>28</volume><issue>27</issue><spage>4275</spage><epage>4279</epage><pages>4275-4279</pages><issn>0732-183X</issn><eissn>1527-7755</eissn><abstract>New technologies are constantly being developed and introduced into medical practice. Their potential or actual use raises questions of efficacy and cost. All too often financial considerations of profit primarily determine whether a technology will be adopted. In an era in which the need to control costs has become clear, this situation is undesirable. The assessment of efficacy can, however, be very difficult, and the control of financial aspects is likewise problematic. In this article, we address these problems and suggest potential solutions, using proton radiotherapy as an example that may be relevant to the development of other medical devices.</abstract><cop>Alexandria, VA</cop><pub>American Society of Clinical Oncology</pub><pmid>20697074</pmid><doi>10.1200/JCO.2010.29.4645</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0732-183X |
| ispartof | Journal of clinical oncology, 2010-09, Vol.28 (27), p.4275-4279 |
| issn | 0732-183X 1527-7755 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_755189246 |
| source | MEDLINE; American Society of Clinical Oncology Online Journals; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| subjects | Biological and medical sciences Clinical Trials as Topic Cost Control Diffusion of Innovation Equipment Design Evidence-Based Medicine Health Care Costs Humans Medical sciences Patient Selection Protons - therapeutic use Radiotherapy - economics Radiotherapy - instrumentation Technology Transfer Treatment Outcome Tumors |
| title | Technology Evolution: Is It Survival of the Fittest? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T00%3A30%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Technology%20Evolution:%20Is%20It%20Survival%20of%20the%20Fittest?&rft.jtitle=Journal%20of%20clinical%20oncology&rft.au=ZIETMAN,%20Anthony&rft.date=2010-09-20&rft.volume=28&rft.issue=27&rft.spage=4275&rft.epage=4279&rft.pages=4275-4279&rft.issn=0732-183X&rft.eissn=1527-7755&rft_id=info:doi/10.1200/JCO.2010.29.4645&rft_dat=%3Cproquest_cross%3E755189246%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=755189246&rft_id=info:pmid/20697074&rfr_iscdi=true |